Skip to main content

Applied Biosystems, Biocrates Ink Co-marketing Pact

NEW YORK (GenomeWeb News) – Biocrates Life Sciences said today that it has forged a worldwide co-marketing agreement with Applied Biosystems focused on the metabolomics market.
Innsbruck, Austria-based Biocrates will promote ABI’s mass spectrometers for targeted metabolomics and for use in combination with its AbsoluteIDQ kits. In return, ABI will promote Biocrates’ AbsolteIDQ kits for targeted metabolomics in combination with its triple quadrupole and QTRAP series instruments.
Biocrates launched the AbsoluteIDQ kit at the recent Aanalytica meeting in Munich, Germany. The kits are initially available only in Europe, but the firm plans to expand sales to the US and eventually the rest of the world, it said.
“Metabolomics is a growing field expected to expand the market for mass spectrometers worldwide,” Tamara Bond, senior director of the pharmaceutical business at ABI, said in a statement.
The firms expect to jointly market the combined technologies at upcoming conferences including the American Society of Mass Spectrometry in Denver, Colo., next week.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.